Panacea Biotec has entered into long term agreement (LTA) with UNICEF for supply of Pentavalent Vaccine (Easyfive-TT) in calendar year 2017 and also received a Notification from Pan American Health Organization (PAHO) for purchase of Pentavalent Vaccine (Easyfive-TT) in the event PAHO should have any requirements through December 31, 2019.
Total value of this expected business from UN Agencies is worth $20.475 million equivalent to around Rs 140 crore based on current exchange rate.
Panacea Biotec is one of the India’s leading research based health management companies with established research, manufacturing and marketing capabilities.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: